Lessons Learned is STAT Plus’ column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us for useful tips. And if you’ve recently jumped, send us a note: kate.sheridan@statnews.com. Your experience might make a future column.

Who we talked to: Joe Burns, 35, head of biology at Decibel Therapeutics, Cambridge, Mass.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Great article. There are a lot of great ways to use a PhD and a lot of interesting problems to solve in academia, in government, and in the private sector.

    My advisor was a bit disappointed when I didn’t choose academia, but I’ve never regretted it and always had interesting problems to work on (and never had to spend a day chasing a grant).

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy